- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03835299
Addressing Fear and Risk of Vasovagal Reactions Among High School Donors
September 14, 2021 updated by: Christopher R. France, Ph.D., Ohio University
In this study, high school donors will be asked about their blood donation-related fears prior to their donation.
Half of the donors reporting fear will be assigned to a brief coping skills intervention.
Study Overview
Detailed Description
In this study the investigators will ask high school donors about their blood donation-related fears prior to their donation.
Among those who report donation fear, half will be randomly assigned to receive a brief presentation of coping strategies administered via a computer tablet.
The investigators will compare reaction rates and return behavior for the donors and high school drives where the study was conducted to the reaction and retention rates from similar blood drives where no data was collected.
The investigators will also examine whether asking about the specific types of fear improves the prediction of syncopal or presyncopal reactions beyond the predictive value of a single fear question.
Finally, the investigators will examine whether providing coping information to help manage the fear improves syncopal reaction rates and/or donor retention rates among fearful donors.
Study Type
Interventional
Enrollment (Actual)
4035
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Athens, Ohio, United States, 45701
- Ohio University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- To be eligible for inclusion in this study, the individual must have presented to donate blood at a New York Blood Center high school blood drive where data is being collected and have passed the health screening process.
Exclusion Criteria:
- Less than 16 years of age; inability to read and comprehend English
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Fear Control
Participants who report blood donation-related fear who are assigned to this study arm will answer several questions then proceed through the normal blood donation process.
|
|
EXPERIMENTAL: Fear Intervention
Participants who report blood donation-related fear who are assigned to this study arm will answer several questions and view a brief presentation of coping strategies presented via a computer tablet.
They will then proceed through the normal blood donation process.
|
Coping information related to the fear that was identified by the participant will be presented via a computer tablet.
|
NO_INTERVENTION: No Fear Control
Participants who report no blood donation-related fear will proceed through the normal blood donation process.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Repeat Blood Donation Attempts
Time Frame: two years post-donation
|
Donor records will be used to track subsequent donation attempts during the follow-up.
|
two years post-donation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood Donation Confidence
Time Frame: immediately pre-donation
|
Confidence in ability to cope with any donation-related fear
|
immediately pre-donation
|
Vasovagal Reactions to Blood Donation
Time Frame: immediately post-donation
|
phlebotomist ratings of blood donor vasovagal reactions
|
immediately post-donation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
February 15, 2019
Primary Completion (ACTUAL)
January 15, 2020
Study Completion (ACTUAL)
January 15, 2020
Study Registration Dates
First Submitted
February 7, 2019
First Submitted That Met QC Criteria
February 7, 2019
First Posted (ACTUAL)
February 8, 2019
Study Record Updates
Last Update Posted (ACTUAL)
September 16, 2021
Last Update Submitted That Met QC Criteria
September 14, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NYBC 1243761
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Donors
-
Ohio UniversityNational Heart, Lung, and Blood Institute (NHLBI); New York Blood CenterCompleted
-
Universidad Peruana Cayetano HerediaCompleted
-
Guangzhou Blood CenterUnknown
-
University of MinnesotaNational Heart, Lung, and Blood Institute (NHLBI); Syracuse University; Liverpool... and other collaboratorsCompleted
-
Universidad Peruana Cayetano HerediaCompleted
-
Ohio UniversityNew York Blood CenterCompleted
-
Ohio UniversityNew York Blood Center; Hoxworth Blood CenterCompleted
-
BloodworksNational Heart, Lung, and Blood Institute (NHLBI)CompletedBlood Donors
-
National Institute of Allergy and Infectious Diseases...CompletedLiving Donors | Tissue Donors
-
National Institutes of Health Clinical Center (CC)RecruitingBlood Donors | Apheresis | Research SubjectsUnited States
Clinical Trials on Fear Intervention
-
Columbia UniversityNational Institute on Aging (NIA)CompletedCardiac Arrest | Post Traumatic Stress SyndromeUnited States
-
University of Illinois at ChicagoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Loyola...CompletedType 1 Diabetes MellitusUnited States
-
Ottawa Hospital Research InstituteCompleted
-
Tampere UniversityFinnish Institute for Health and Welfare; Kanta-Häme Central Hospital; Metropolia...Active, not recruitingDepression | Anxiety | Fear of ChildbirthFinland
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingStage III Lung Cancer AJCC v8 | Advanced Lung Carcinoma | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Malignant Female Reproductive System Neoplasm | Stage IIIC Lung Cancer AJCC v8United States
-
Stanford UniversityUniversity of Colorado, Denver; University of South Florida; Indiana UniversityCompletedType 1 Diabetes MellitusUnited States
-
Columbia UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedMedication Adherence | Acute Coronary Syndrome | FearUnited States
-
University of Texas at AustinCompletedSocial Anxiety DisorderUnited States
-
University of Texas at AustinRecruiting